Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine

KOVÁŘOVÁ, H., M. HAJDÚCH, G. KOŘÍNKOVÁ, P. HALADA, S. KRUPIČKOVÁ, A. GOULDSWORTHY, N. ZHELEV, M. STRNAD
Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine. Electrophoresis. 2000, 21(17), 3757-3764, ISSN: 0173-0835, PMID: 11271495,